International Journal of Peptide Research and Therapeutics
Scope & Guideline
Fostering Global Collaboration in Peptide Innovation.
Introduction
Aims and Scopes
- Therapeutic Applications of Peptides:
The journal investigates the use of peptides in various therapeutic contexts, including antimicrobial, anticancer, anti-inflammatory, and immunomodulatory applications. This includes the study of naturally occurring peptides, synthetic analogs, and engineered peptide constructs. - Peptide Design and Engineering:
Research published in this journal often focuses on the design, synthesis, and characterization of novel peptides. This includes the use of computational approaches, molecular docking, and structure-activity relationship studies to optimize peptide efficacy and specificity. - Mechanisms of Action:
The journal emphasizes understanding the biochemical and molecular mechanisms through which peptides exert their effects, including studies on signal transduction pathways, receptor interactions, and cellular responses. - Bioinformatics and Computational Modeling:
A significant portion of the research involves computational methods for predicting peptide interactions, designing peptide-based vaccines, and simulating the behavior of peptides in biological systems. - Natural Product Research:
The journal highlights the exploration of peptides derived from natural sources, including plants, animals, and microorganisms, and their potential therapeutic benefits. - Multidisciplinary Approaches to Peptide Research:
Research often integrates various scientific disciplines such as biochemistry, molecular biology, pharmacology, and materials science to advance the field of peptide therapeutics.
Trending and Emerging
- Antimicrobial Peptides (AMPs):
There is a growing body of research focused on the discovery, characterization, and application of antimicrobial peptides as alternatives to conventional antibiotics, particularly in addressing multidrug-resistant pathogens. - Peptide Vaccines:
The development of peptide-based vaccines, particularly in response to emerging infectious diseases such as COVID-19, has gained significant attention, with many studies exploring immunogenicity and efficacy. - Peptides in Cancer Therapy:
Research on peptides that target cancer cells, including their mechanisms of action and potential as therapeutic agents, is rapidly expanding, with a focus on novel delivery systems and combination therapies. - AI and Machine Learning in Peptide Design:
The integration of artificial intelligence and machine learning techniques in peptide design and optimization is emerging as a powerful tool, enhancing the ability to predict peptide interactions and therapeutic potential. - Natural and Synthetic Hybrid Peptides:
There is an increasing interest in hybrid peptides that combine properties of natural and synthetic peptides, aiming to enhance stability and efficacy for therapeutic applications. - Peptides for Neurological Disorders:
Research on the role of peptides in the treatment of neurological conditions, including neurodegenerative diseases and neuroinflammation, is on the rise, highlighting their therapeutic potential in the central nervous system.
Declining or Waning
- Traditional Antibiotics:
There appears to be a waning interest in the development of traditional peptide antibiotics as researchers increasingly focus on innovative approaches, such as multifunctional peptides or peptide-drug conjugates, to combat antibiotic resistance. - Peptides for General Health Supplements:
Research focused on the use of peptides exclusively for general health benefits or as dietary supplements is becoming less prominent, indicating a shift toward more targeted therapeutic applications. - Peptide-Based Diagnostics:
The exploration of peptides specifically for diagnostic applications has decreased, possibly as the field shifts towards integrated approaches that combine diagnostics with therapeutic interventions. - Basic Research in Peptide Chemistry:
While fundamental studies are essential, there is a noticeable decline in publications that focus solely on the basic chemistry of peptides without direct therapeutic implications, reflecting a trend toward more applied research.
Similar Journals
MOLECULAR DIVERSITY
Pioneering Insights into Molecular ComplexityMOLECULAR DIVERSITY, published by Springer, stands as a pivotal platform within the fields of chemistry, biology, and pharmacology since its inception in 1995. This esteemed journal aims to foster interdisciplinary research and innovation, particularly in areas such as catalysis, drug discovery, inorganic and organic chemistry, and molecular biology. With a diverse scope that reflects contemporary scientific challenges, it has been recognized for its significant contributions, boasting commendable Scopus rankings and an impact factor that underscores its relevance in critical fields. Although not an open access journal, MOLECULAR DIVERSITY continues to influence and engage researchers, professionals, and students alike by providing a forum for high-quality peer-reviewed articles and cutting-edge research findings. As it converges years of scientific dynamism from 1995 to 2024, this journal remains vital for those advancing the frontiers of molecular science and engineering.
RSC Medicinal Chemistry
Your Gateway to Cutting-Edge Medicinal ResearchRSC Medicinal Chemistry is a pivotal journal in the realm of medicinal chemistry, published by the esteemed Royal Society of Chemistry. With a focus on innovative research that intersects various disciplines such as biochemistry, drug discovery, pharmaceutical science, and organic chemistry, this journal serves as a vital resource for researchers, professionals, and students alike. Its impressive impact factor and notable rankings—positioning it within the Q1 and Q2 quartiles across critical categories—underscore its significance in advancing knowledge and fostering collaboration within the scientific community. RSC Medicinal Chemistry is dedicated to open access, ensuring that cutting-edge findings on drug design and therapeutic applications are freely available to enhance global research efforts. With a commitment to publication excellence from 2020 to 2024, it is a prominent platform where groundbreaking ideas meet practical implications, making it indispensable for anyone committed to the forefront of medicinal advances.
CELL BIOCHEMISTRY AND BIOPHYSICS
Exploring the Frontiers of Cellular ScienceCELL BIOCHEMISTRY AND BIOPHYSICS is a distinguished journal published by HUMANA PRESS INC, focusing on critical advancements in the fields of biochemistry, biophysics, and cell biology. Since its establishment, the journal has provided a robust platform for the dissemination of cutting-edge research, covering diverse aspects of cellular biochemistry and the physical principles that underlie biological systems. With an emphasis on interdisciplinary studies, the journal aims to facilitate knowledge exchange among researchers, professionals, and students from various scientific backgrounds. As reflected in its 2023 category rankings, it holds a respectable position in Q3 for Biochemistry and Cell Biology, and Q2 for both Biophysics and Medicine (miscellaneous), indicating its significant contribution to these fields. Although it operates under a subscription model, the journal's commitment to maintaining high publication standards ensures that only impactful studies are shared with its audience. With a range of articles spanning theoretical insights to practical applications, CELL BIOCHEMISTRY AND BIOPHYSICS is an essential resource for those aiming to stay at the forefront of biochemical and biophysical research.
European Journal of Medicinal Chemistry Reports
Fostering collaboration for groundbreaking medicinal advancements.European Journal of Medicinal Chemistry Reports, published by ELSEVIER, is a vital platform dedicated to advancing the field of medicinal chemistry through open access communication of high-quality research. With an impact factor reflecting its growing influence, this journal has rapidly established a reputation for scholarly excellence since its launch in 2021. It serves as a converging point for innovative studies and reviews that span the disciplines of chemistry and molecular medicine, reflected in its Q2 and Q3 quartile rankings in relevant categories for 2023. Situated in France, the journal is accessible globally, ensuring that researchers, professionals, and students can easily engage with significant findings and methodologies in medicinal chemistry. The open access model facilitates the dissemination of knowledge, bridging gaps between laboratory research and practical applications in drug development. By fostering collaboration and highlighting emerging trends, the European Journal of Medicinal Chemistry Reports plays a crucial role in shaping the future of therapeutic innovations.
Peptide Science
Bridging disciplines with cutting-edge peptide research.Peptide Science, published by Wiley, is an esteemed journal dedicated to advancing the understanding of peptide chemistry and its applications across various scientific disciplines, including biochemistry, biophysics, and organic chemistry. Since its inception in 2018 and continuing through 2024, this journal has provided an essential platform for the dissemination of innovative research, engaging articles, and critical reviews. With an impressive Q3 ranking in the fields of Biochemistry and Biomaterials, and a Q2 status in Biophysics and Organic Chemistry as of 2023, Peptide Science acknowledges its integral role in addressing significant scientific challenges. This open-access journal ensures that findings are readily available to a global audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. The journal exemplifies excellence in scholarly communication, making it an essential resource for anyone interested in the intricate world of peptide research.
Letters in Drug Design & Discovery
Advancing the Frontiers of Drug DiscoveryLetters in Drug Design & Discovery is an esteemed journal dedicated to advancing the fields of Drug Discovery and Molecular Medicine. Published by Bentham Science Publishers, this journal offers a platform for the dissemination of innovative research and advanced methodologies, enhancing collaboration among researchers and professionals in pharmaceutical sciences. Despite its current Q4 ranking in Drug Discovery and Molecular Medicine and Q3 in Pharmaceutical Science for 2023, the journal is committed to improving its presence in the academic community by providing quality, peer-reviewed publications that cover various aspects of drug design and discovery, including novel therapeutic approaches and methodologies. With a focus on both foundational and cutting-edge research from around the globe, Letters in Drug Design & Discovery is pivotal for those seeking to stay abreast of developments in drug development and molecular research. Researchers are encouraged to submit their work, engage with the burgeoning field, and contribute to the ongoing dialogue driven by this journal, which spans the years from 2005 to 2024. While the journal does not currently offer open access, its contributions remain accessible to a wide range of academic and professional audiences.
PROTEIN JOURNAL
Transforming Insights into Biomedical ApplicationsProtein Journal, published by Springer, stands as a significant academic resource in the fields of Analytical Chemistry, Biochemistry, Bioengineering, and Organic Chemistry. Since its inception in 1996, the journal has dedicated itself to the dissemination of high-quality research focused on protein chemistry and its biomedical applications. With an impressive impact reflected in its classification as a Q2 journal in Analytical Chemistry and Q3 in both Biochemistry and Bioengineering as of 2023, it provides an essential platform for researchers and practitioners to share their findings. The journal embraces the open-access model, enhancing accessibility to cutting-edge research. The Protein Journal is crucial for academicians, industry professionals, and students, catering to their need for rigorous scientific discourse and innovative discoveries in protein studies. With an established track record of converging over two decades of knowledge and research, it continues to influence and shape the advancements in this vital area of science.
PROTEIN AND PEPTIDE LETTERS
Pioneering pathways in therapeutic applications of proteins and peptides.PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
Unlocking the Mysteries of Signal TransductionJOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.
PEPTIDES
Unlocking the Secrets of Peptide SciencePEPTIDES, published by Elsevier Science Inc, is a premier journal in the field of Biochemistry that has made a significant impact since its inception in 1980. With a current Impact Factor that places it in the Q2 and Q3 quartiles across multiple categories—including Cellular and Molecular Neuroscience and Endocrinology—this journal serves as a vital resource for researchers and professionals seeking to advance their understanding of peptide biology and its broad implications in health and disease. The journal's Scopus ranking reflects its relevance and esteemed contributions, ranking in the top percentiles in various biological disciplines. While currently not available as an open-access option, the depth of peer-reviewed research articles, reviews, and communications offered aims to push the boundaries of knowledge in physiology and molecular biology. As it converges towards 2024, PEPTIDES continues to be a beacon for innovative research that inspires the next generation of scientists.